News Releases

October 2, 2014

RepliCel to Present Clinical Trial Update at Stem Cell Meeting on the Mesa Partnering Forum in California
VANCOUVER, BC – October 2, 2014 – RepliCel Life Sciences Inc. (TSX.V: RP) (OTCQB: REPCF), clinical stage regenerative medicine company focused on the development... Read full article

September 12, 2014

RepliCel Retains Market-Making Services
VANCOUVER, BC – September 12, 2014 – RepliCel Life Sciences Inc. (TSXV: RP) (OTCQB: REPCF) (“RepliCel” or the “Company”) has, subject to regulatory approval,... Read full article

September 9, 2014

RepliCel Garners Feature on Fox Business News and the Financial Post
RepliCel’s Innovative Technology Converts Your Own Cells into Products to Repair and Rejuvenate the Body VANCOUVER, BC – September 9, 2014 – RepliCel Life... Read full article

September 4, 2014

RepliCel to Present at Rodman & Renshaw’s 16th Annual Global Investment Conference in New York
VANCOUVER, BC – September 4, 2014 – RepliCel Life Sciences Inc. (OTCQB: REPCF) (TSXV: RP), a clinical stage regenerative medicine company focused on the development... Read full article

September 3, 2014

RepliCel Life Sciences Joins Centre for Commercialization of Regenerative Medicine, Industry Consortium
CCRM and RepliCel to Partner on Development of Cell Therapies for Tendon Repair VANCOUVER, BC and Toronto, ON – September 3, 2014 – RepliCel... Read full article

August 26, 2014

RepliCel Announces 2014 Second Quarter Financial Results
VANCOUVER, BC – August 26, 2014 – RepliCel Life Sciences Inc.  (the “Company” or “RepliCel”)(TSXV:RP) (OTCQB: REPCF) a regenerative medicine company developing proprietary autologous... Read full article

July 16, 2014

RepliCel Appoints Brooke Hurford as Corporate Secretary and Director, Finance
VANCOUVER, BC – July 16, 2014 – RepliCel Life Sciences Inc. (the “Company”) (TSXV: RP) (OTCQB: REPCF), today announced that it has appointed Brooke... Read full article

June 20, 2014

RepliCel Retains O&M Partners to Coordinate North American Focused Investor Marketing Campaign
VANCOUVER, BC – June 20, 2014 – RepliCel Life Sciences Inc. (TSXV: RP) (OTCQB: REPCF), today announced that it has retained O&M Partners, LLC... Read full article

June 17, 2014

RepliCel Life Sciences Announces Closing of Third and Final Tranche of Private Placement
VANCOUVER, BC – June 17, 2014 – RepliCel Life Sciences Inc. (“RepliCel” or the “Company”) (OTCQB: REPCF) (TSXV: RP), is pleased to announce it... Read full article

June 5, 2014

RepliCel Retains Christina Cameron as Canadian Investor Relations Consultant
VANCOUVER, BC – June 5, 2014 – RepliCel Life Sciences Inc. (TSXV: RP) (OTCQB: REPCF), today announced that it has retained Christina Cameron as... Read full article